Added to YB: 2023-10-08
Pitch date: 2023-10-08
ZYNE [bullish]
Harmony Biosciences Management, Inc.
+4.84%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Harmony Biosciences Management, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.
Market Cap
$65.6M
Pitch Price
$1.24
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.78
P/E
-1.62
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
ZYNERBA PHARMACEUTICALS INC ZYNE
A summary for this pitch has not been created yet.
Read full article (0 min)